from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2336/-

LFCtreatmentdescriptionclass of inhibitor

-0.237

Amikacinug/mL Amikacintranslation

1.434

Cap5-10ug/mL Capreomycintranslation

0.317

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.130

Rif0.2-5ug/mL Rifampicintranscription

0.000

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.693

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.624

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.517

CPZ10-50 ug/mL Chlorpromazinerespiration

0.171

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.261

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.299

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.011

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.326

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.226

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.523

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.720

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.025

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.299

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.179

KCN5-20 ug/mL Potassium cyaniderespiration

0.103

NaN30.2-2 mM Sodium aziderespiration

1.115

Nigericin50 uM Nigericinrespiration

0.314

TRC10-150 ug/mL Triclosanrespiration

-0.501

TRZ10-25 ug/mL Thioridazinerespiration

-0.650

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-2.048

menadione6-10 ug/mL Menadionerespiration

-0.449

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.184

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.608

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.463

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.234

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

-0.411

Cephalexin20-100 ug/mL CephalexincellWall

0.153

Cerulenin0.32-5 ug/mL CerulenincellWall

0.425

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.268

EMB10-20 ug/mL EthambutolcellWall

-0.323

Eta12-40 ug/mL EthionamidecellWall

1.736

INH0.2-0.4 ug/mL IsoniazidcellWall

-2.057

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.365

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.651

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.047

BZA0.12 mg/mL BenzamidearomaticAmides

0.316

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.055

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.561

H2O24 mM hydrogen peroxideDNAdamaging

-0.362

Levo10 ug/mL LevofloxacinDNAdamaging

-0.072

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.172

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.472

UVUV-irradiationDNAdamaging

-0.244

ARP41-4 ug/mL Antitubercular compound ARP4?

0.610

Antimycin12.5-50 ug/mL Antimycin A?

0.265

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.173

PA_110-50 ug/mL Antitubercular compound PA-1?

0.468

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.908

PA8240.2-2 ug/mL PA-824?

-1.045

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.002

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.598

Verapamil50 uM Verapamil?

0.172

mercaptoethanol2 mM 2-Mercaptoethanol?

0.203

methoxatin10-20 ug/mL Methoxatin?